Search Results

You are looking at 1 - 10 of 134 items for :

  • "pharmaceuticals" x
  • Behavioral Sciences x
  • All content x
Clear All
Journal of Behavioral Addictions
Authors: Thomas McLaughlin, Kenneth Blum, Marlene Oscar-Berman, Marcelo Febo, Gozde Agan, James L. Fratantonio, Thomas Simpatico, and Mark S. Gold

Blum , K. , Gardner , E. , Oscar-Berman , M. & Gold , M. ( 2012 ). “Liking” and “wanting” linked to Reward Deficiency Syndrome (RDS): Hypothesizing differential responsivity in brain rewardcircuitry . Current Pharmaceutical Design , 18

Open access

undergoing rapid change. As clinical trial successes are publicized and mainstream media interest grows, the ground is fertile for pharmaceutical activity. This commentary piece was originally written for an audience of psychiatrists, therapists, and

Open access

regulations 45 CFR 46.101(b). Results Of the 35 included news stories, 15 were precipitated by scientific publications (43%); 10 by lawsuits (29%); 7 by conference presentations (20%); 1 by a change in pharmaceutical company

Open access

the draft. All authors approved the final product. Conflict of interest The authors declare no conflicts of interest. Dr Potenza has consulted for Opiant Therapeutics, Game Day Data, the Addiction Policy Forum, AXA, and Idorsia Pharmaceuticals; has

Open access

, love and security. While this is the promise of psychedelics, it is not guaranteed. Despite the great hopes of the pharmaceutical industry, as well as a cultural predilection for “quick-fixes”, healing is not simply a function of the psychedelic

Open access

Risk reduction and harm prevention in technology use. •

A commentary on Swanton et al.'s (2020) ‘Problematic risk-taking involving emerging technologies: A stakeholder framework to minimize harms’

Journal of Behavioral Addictions
Author: Daria J. Kuss

system has been suggested in line with the system available for pharmaceuticals to address harms. Age appropriate design and data protection law implementation has also been called for ( Royal College of Psychiatrists, 2020 ). Swanton et al. (2020

Open access
Journal of Psychedelic Studies
Authors: Cody Sykes Gilbert, Mitch Earleywine, Maha N. Mian, and Brianna R. Altman

://doi.org/10.1001/jama.288.11.1403 . 10.1001/jama.288.11.1403 Bultman , D. C. , & Svarstad , B. L. ( 2002 ). Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy . Journal of the American Pharmaceutical

Open access

Considering existing classic and contemporary proposals for preventing online addiction problems: Some old recipes for new problems. •

Commentary on: Problematic risk-taking involving emerging technologies: A stakeholder framework to minimize harms (Swanton et al., 2019)

Journal of Behavioral Addictions
Author: Olatz Lopez-Fernandez

epidemiological research for the last decade . Current Pharmaceutical Design , 20 ( 25 ), 4026 – 4052 . 10.2174/13816128113199990617 Lee , S. Y. , Kim , M. S. , & Lee , H. K. ( 2019 ). Prevention strategies and interventions for internet use disorders

Open access

psychosocial and pharmaceutical treatment, singly and combined, in order to identify the most effective and personalised therapies in this growing area of clinical concern. Funding sources PH was supported by Internal Grant (BST, no 181400-32) of Psychology

Open access

publication. Conflict of interest The authors have no interests or activities that might be seen as influencing the research (e.g., financial interests in a test or procedure, funding by pharmaceutical companies for research

Open access